ENDOMETRIAL ADENOCARCINOMA

This study is testing several drug combinations to see if they work better than single drugs at controlling advanced endometrial cancer that has returned or spread. It involves 288 women whose cancer has come back after prior treatment. Researchers are comparing different pairs o…

This study aims to find the most effective drug combination for treating advanced or returning endometrial (uterine) cancer. It randomly assigned 349 patients to receive one of three different chemotherapy and targeted drug regimens. Researchers are comparing how well each combin…

This early-stage study is testing a combination of two drugs, niraparib (a pill) and copanlisib (an IV infusion), for women whose ovarian, endometrial, or related cancers have returned after prior treatment. The main goals are to find the safest dose of this combination and to le…

This study is testing whether a new combination of two drugs, cadonilimab and lenvatinib, can help control advanced endometrial cancer that has continued to grow after standard chemotherapy. It will involve about 32 patients to see how well the combination shrinks tumors and how …

This study is testing whether adding an experimental drug (BMS-986205) to an existing immunotherapy (nivolumab) works better for controlling recurrent endometrial cancer. It is for women whose cancer has come back after initial platinum-based chemotherapy. The main goal is to see…

This early-stage trial is testing the safety and best doses of two different combinations of oral medications for people with recurrent endometrial, ovarian, or triple-negative breast cancer. The study combines an existing drug (olaparib) with one of two newer drugs (AZD2014 or A…